Explore

Trendline Trendline
David Sinclair Launches Lifespan Media Platform to Advance Longevity Science

David Sinclair Launches Lifespan Media Platform to Advance Longevity Science

David Sinclair Launches Lifespan Media Platform to Advance Longevity Science
Trendline Trendline
X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements

X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements

X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements
Rapid Read Rapid Read
Study Explores Why Some People Never Develop Cancer

Study Explores Why Some People Never Develop Cancer

A new study, ATLAS, is investigating why some individuals never develop cancer despite exposure to high-risk factors. The research focuses on autoantibodies, immune-system proteins that mistakenly target healthy cells. These proteins are known for their role in autoimmune diseases but may also influence cancer immunity. The study aims to analyze blood samples from diverse groups, including centenarians and individuals with high-risk gene variants, to understand how autoantibodies might contribute to cancer resistance. The findings could lead to new diagnostic tests and treatments by uncovering fundamental principles of antibody immunity in cancer.
Rapid Read Rapid Read
AI-Designed Viruses: Potential Breakthroughs and Ethical Concerns

AI-Designed Viruses: Potential Breakthroughs and Ethical Concerns

Researchers at the Arc Institute and Stanford University have used AI models to design new viruses capable of infecting bacteria. The study, published in Science, aims to advance gene therapy and biotechnology. However, the potential misuse of AI-designed viruses raises ethical concerns, as they could be used to create harmful biological agents. The study highlights the need for strict regulations and ethical guidelines in AI-driven research.
Rapid Read Rapid Read
Texas A Researchers Unveil Full Genetic Blueprint of Zoysia Grass

Texas A Researchers Unveil Full Genetic Blueprint of Zoysia Grass

Researchers at Texas A&M AgriLife have successfully mapped the full genetic blueprint of zoysia grass, a popular turfgrass used in lawns and sports fields across the southern and transitional U.S. regions. This breakthrough was achieved by a team led by Murukarthick Jayakodi, Ph.D., and is expected to significantly enhance the precision of turfgrass genetics and breeding. The newly discovered genome allows scientists to identify genes responsible for traits such as stress tolerance, which is crucial for developing more resilient grass varieties. This advancement is expected to streamline the breeding process, reducing the time and effort traditionally required for field testing.
Trendline Trendline
Valter Longo Discusses Efficacy of Longevity Treatments Amid Growing Market

Valter Longo Discusses Efficacy of Longevity Treatments Amid Growing Market

Valter Longo Discusses Efficacy of Longevity Treatments Amid Growing Market
Trendline Trendline
Atossa Therapeutics Advances Breast Cancer Treatment with Phase 2 Drug Development

Atossa Therapeutics Advances Breast Cancer Treatment with Phase 2 Drug Development

Atossa Therapeutics Advances Breast Cancer Treatment with Phase 2 Drug Development
Rapid Read Rapid Read
Kriya Therapeutics Reports Success in Extending Lifespan with Gene Therapy in Mice

Kriya Therapeutics Reports Success in Extending Lifespan with Gene Therapy in Mice

Kriya Therapeutics has published preclinical data showing that a single administration of AAV-FGF21 gene therapy extended the lifespan and health span of aged mice. The therapy improved metabolic functions, preserved organ health, and maintained muscle strength and memory. These findings suggest that FGF21 gene therapy could be a promising strategy for promoting healthy aging and treating metabolic disorders. The study, led by Professor Fátima Bosch, highlights the potential of gene therapy to address age-related diseases and improve quality of life.
Trendline Trendline
Cellectis Advances Gene Therapy Trials with FDA Designation for Lasme-cel

Cellectis Advances Gene Therapy Trials with FDA Designation for Lasme-cel

Cellectis Advances Gene Therapy Trials with FDA Designation for Lasme-cel
Trendline Trendline
Gene-Edited Puppies Offer Allergy-Free Pet Ownership

Gene-Edited Puppies Offer Allergy-Free Pet Ownership

Gene-Edited Puppies Offer Allergy-Free Pet Ownership
Trendline Trendline
INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment

INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment

INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment
Trendline Trendline
AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges

AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges

AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges